Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

著者: Lais Osmani, Frederic B. Askin, Edward Gabrielson, Qing Kay Li - Seminars in Cancer Biology 2017 被引用: 830